The top five identified DElncRNAs according to absolute weighted-effect size included four DElncRNAs that had no previously characterized roles in glioblastoma; RNFT1-DT, ENSG00000233184, ENSG00000268205 and ENSG00000268362, as well as glioblastoma prognostic biomarker MROCKI (LINC01268) [49]. This evidence concerns the gene RNFT1 and glioblastoma.